September 26, 2023
GSK Announces Largest Private Financial Contribution to CIHR’s Team Grants Initiative Addressing Threats to Canadian Lung Health
August 4, 2023
GSK’s Arexvy, the First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults Approved in Canada
June 28, 2023
GSK Completes Acquisition of BELLUS Health
No current content.